Innovent Biologics

Hong Kong stocks slipped on Monday, snapping a two-day rebound, as investors stayed cautious and awaited clearer policy direction ahead…

The ferocity of China’s biopharmaceutical investment boom this year – fuelled by record-breaking licensing of commercial rights to global giants…

American pharmaceutical giant Pfizer’s up to US$7.3 billion acquisition of next-generation weight loss drugs developer Metsera will encourage more research…

Biotech firm Ascletis Pharma said ASC47, its muscle-preserving weight loss drug candidate, could boost the efficacy of the popular anti-obesity…

In the summer of 2015, a time when China’s pharmaceutical market was in a phase of rapid expansion, a sudden…

Momentum in the Hong Kong fundraising market that comes after initial public offerings (IPOs) is set to continue, senior investment…

The global market for diabetes drugs used for treating obesity is expected to expand in Asia, as new players jostle…